QQ客服 官方微博 反馈留言

	Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia
	Peng, Guangxin; Yang, Wenrui; Zhang, Li; Zhou, Kang; Li, Yang; Li, Yuan; Ye, Lei; Li, Jianping; Fan, Huihui; Song, Lin
	2016
卷号	21期号:3页码:138-143
关键词	T-cell large granular lymphocyte leukemia Cyclophosphamide Cyclosporine A Pure red cell aplasia
ISSN号	1024-5332
DOI	10.1080/10245332.2015.1101977
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6382093
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Peng, Guangxin,Yang, Wenrui,Zhang, Li,et al. Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia[J],2016,21(3):138-143.
APA	Peng, Guangxin.,Yang, Wenrui.,Zhang, Li.,Zhou, Kang.,Li, Yang.,...&Jing, Liping.(2016).Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia.,21(3),138-143.
MLA	Peng, Guangxin,et al."Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia".21.3(2016):138-143.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。